Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alessia Carocci, Alessia Catalano & Maria Stefania Sinicropi. (2014) Melatonergic drugs in development. Clinical Pharmacology: Advances and Applications 6, pages 127-137.
Read now
Read now
Alberto Dominguez-Rodriguez. (2012) Melatonin in cardiovascular disease. Expert Opinion on Investigational Drugs 21:11, pages 1593-1596.
Read now
Read now
Ludovit Paulis, Fedor Simko & Moshe Laudon. (2012) Cardiovascular effects of melatonin receptor agonists. Expert Opinion on Investigational Drugs 21:11, pages 1661-1678.
Read now
Read now
D Alan Lankford. (2011) Tasimelteon for insomnia. Expert Opinion on Investigational Drugs 20:7, pages 987-993.
Read now
Read now
Marco Mor, Silvia Rivara, Daniele Pala, Annalida Bedini, Gilberto Spadoni & Giorgio Tarzia. (2010) Recent advances in the development of melatonin MT1 and MT2 receptor agonists. Expert Opinion on Therapeutic Patents 20:8, pages 1059-1077.
Read now
Read now
Articles from other publishers (43)
Timo Partonen. 2023. Encyclopedia of Sleep and Circadian Rhythms. Encyclopedia of Sleep and Circadian Rhythms
755
760
.
Sibel Suzen. 2023. Emerging Anti-Aging Strategies. Emerging Anti-Aging Strategies
155
189
.
Rüdiger Hardeland. (2022) Redox Biology of Melatonin: Discriminating Between Circadian and Noncircadian Functions. Antioxidants & Redox Signaling 37:10-12, pages 704-725.
Crossref
Crossref
Rüdiger Hardeland. (2021) Divergent Importance of Chronobiological Considerations in High- and Low-dose Melatonin Therapies. Diseases 9:1, pages 18.
Crossref
Crossref
Dongmei Chen, Tao Zhang & Tae Ho Lee. (2020) Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases. Biomolecules 10:8, pages 1158.
Crossref
Crossref
Jana Tchekalarova, Violina T. Angelova, Nadezhda Todorova, Pavlina Andreeva-Gateva & Miroslav Rangelov. (2019) Evaluation of the anticonvulsant effect of novel melatonin derivatives in the intravenous pentylenetetrazol seizure test in mice. European Journal of Pharmacology 863, pages 172684.
Crossref
Crossref
Ronan Rocaboy, Ioannis Anastasiou & Olivier Baudoin. (2019)
Redox‐Neutral Coupling between Two C(sp
3
)−H Bonds Enabled by 1,4‐Palladium Shift for the Synthesis of Fused Heterocycles
. Angewandte Chemie International Edition 58:41, pages 14625-14628.
Crossref
Crossref
Ronan Rocaboy, Ioannis Anastasiou & Olivier Baudoin. (2019)
Redox‐Neutral Coupling between Two C(sp
3
)−H Bonds Enabled by 1,4‐Palladium Shift for the Synthesis of Fused Heterocycles
. Angewandte Chemie 131:41, pages 14767-14770.
Crossref
Crossref
Si-Yue Chen, Chang-An Geng, Yun-Bao Ma, Xiao-Yan Huang, Xiao-Tong Yang, Li-Hua Su, Xiao-Feng He, Tian-Ze Li, Zhen-Tao Deng, Zhen Gao, Xue-Mei Zhang & Ji-Jun Chen. (2019) Polybenzyls from Gastrodia elata, their agonistic effects on melatonin receptors and structure-activity relationships. Bioorganic & Medicinal Chemistry 27:15, pages 3299-3306.
Crossref
Crossref
Yaoyao Xia, Siyuan Chen, Sijing Zeng, Yuanyuan Zhao, Congrui Zhu, Baichuan Deng, Guoqiang Zhu, Yulong Yin, Wence Wang, Rüdiger Hardeland & Wenkai Ren. (2019) Melatonin in macrophage biology: Current understanding and future perspectives. Journal of Pineal Research 66:2, pages e12547.
Crossref
Crossref
Brian Raymer & Samit K. Bhattacharya. (2018) Lead-like Drugs: A Perspective. Journal of Medicinal Chemistry 61:23, pages 10375-10384.
Crossref
Crossref
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
481
535
.
T. Partonen. 2017. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Rüdiger Hardeland. 2017. Hormones in Ageing and Longevity. Hormones in Ageing and Longevity
209
242
.
SumraWajid Abbasi, Saad Raza, Syed Sikander Azam, Klaus R. Liedl & Julian E. Fuchs. (2016) Interaction mechanisms of a melatonergic inhibitor in the melatonin synthesis pathway. Journal of Molecular Liquids 221, pages 507-517.
Crossref
Crossref
Ya-Mei He, Hong-Hui Deng, Mei-Hong Shi, Bello Musa Bodinga, Hua-Li Chen, Zeng-Sheng Han, Zhong-Liang Jiang & Qing-Wang Li. (2016) Melatonin modulates the functions of porcine granulosa cells via its membrane receptor MT2 in vitro. Animal Reproduction Science 172, pages 164-172.
Crossref
Crossref
Paula Mosińska, Katarzyna Socała, Dorota Nieoczym, Moshe Laudon, Martin Storr, Jakub Fichna & Piotr Wlaź. (2016) Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice. Behavioural Brain Research 307, pages 199-207.
Crossref
Crossref
Rüdiger Hardeland. (2016) Melatonergic Treatment: Focus on Metabolism and Chronobiology. Focus on Sciences 2:1, pages 1-10.
Crossref
Crossref
Rüdiger Hardeland. 2016. Inflammation, Aging, and Oxidative Stress. Inflammation, Aging, and Oxidative Stress
345
376
.
Izaskun Buendia, Vanessa Gómez-Rangel, Laura González-Lafuente, Esther Parada, Rafael León, Isabel Gameiro, Patrycja Michalska, Moshe Laudon, Javier Egea & Manuela G. López. (2015) Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models. Neuropharmacology 99, pages 187-195.
Crossref
Crossref
Rüdiger Hardeland. 2014. Melatonin. Melatonin
11
18
.
Darius. P. Zlotos, Ralf Jockers, Erika Cecon, Silvia Rivara & Paula A. Witt-Enderby. (2013)
MT
1
and MT
2
Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
. Journal of Medicinal Chemistry 57:8, pages 3161-3185.
Crossref
Crossref
Michelle Basler, Alexander Jetter, Daniel Fink, Burkhardt Seifert, Gerd A. Kullak-Ublick & Andreas Trojan. (2014) Urinary Excretion of Melatonin and Association with Breast Cancer: Meta-Analysis and Review of the Literature. Breast Care 9:3, pages 182-187.
Crossref
Crossref
Xuan Zhang, Zhilong Wang, Qingqing Huang, Yu Luo, Xin Xie & Wei Lu. (2014)
Design, synthesis, and biological evaluation of a new class of MT
2
-selective agonists
. RSC Adv. 4:49, pages 25871-25874.
Crossref
Crossref
Darius P. Zlotos. 2014. Melatonin and Melatonergic Drugs in Clinical Practice. Melatonin and Melatonergic Drugs in Clinical Practice
97
116
.
King Chan & Yung Wong. (2013) A Molecular and Chemical Perspective in Defining Melatonin Receptor Subtype Selectivity. International Journal of Molecular Sciences 14:9, pages 18385-18406.
Crossref
Crossref
Jaime M. Monti, Ahmed S. BaHammam, Seithikurippu R. Pandi-Perumal, Vivien Bromundt, D. Warren Spence, Daniel P. Cardinali & Gregory M. Brown. (2013) Sleep and circadian rhythm dysregulation in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 43, pages 209-216.
Crossref
Crossref
Seithikurippu R. Pandi-Perumal, Ahmed S. BaHammam, Gregory M. Brown, D. Warren Spence, Vijay K. Bharti, Charanjit Kaur, Rüdiger Hardeland & Daniel P. Cardinali. (2012) Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes. Neurotoxicity Research 23:3, pages 267-300.
Crossref
Crossref
Elmar Peschke, Ina Bähr & Eckhard Mühlbauer. (2013) Melatonin and Pancreatic Islets: Interrelationships between Melatonin, Insulin and Glucagon. International Journal of Molecular Sciences 14:4, pages 6981-7015.
Crossref
Crossref
Rüdiger Hardeland. (2013) Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus—Consequences to Melatonin Dysfunction. International Journal of Molecular Sciences 14:3, pages 5817-5841.
Crossref
Crossref
Reinhard Oertel, Lisa Goltz & Wilhelm Kirch. (2013) Determination of the novel melatonin agonist Neu-P11 in plasma samples by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 74, pages 66-70.
Crossref
Crossref
R. Oertel, L. Goltz & W. Kirch. (2013) Elucidation of Neu-P11 metabolism in urine of volunteers by liquid chromatography–tandem mass spectrometry. Journal of Chromatography A 1278, pages 69-75.
Crossref
Crossref
T. Partonen. 2013. Encyclopedia of Sleep. Encyclopedia of Sleep
118
121
.
Shou-min Xi, San-qiang Li & Wei-dong Yin. (2012) Topical Application of Melatonin Analogue Neu-P11 Reduces Intraocular Pressure in Normotensive Rabbit. Topical Application of Melatonin Analogue Neu-P11 Reduces Intraocular Pressure in Normotensive Rabbit.
Rüdiger Hardeland, Juan Antonio Madrid, Dun‐Xian Tan & Russel J. Reiter. (2011) Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. Journal of Pineal Research 52:2, pages 139-166.
Crossref
Crossref
Rüdiger Hardeland. (2012) Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction. The Scientific World Journal 2012, pages 1-18.
Crossref
Crossref
Jeffrey M. Ellenbogen & Edward F. Pace-Schott. (2011) Drug-induced sleep: theoretical and practical considerations. Pflügers Archiv - European Journal of Physiology 463:1, pages 177-186.
Crossref
Crossref
Randi Hagerman, Julie Lauterborn, Jacky Au & Elizabeth Berry-Kravis. 2012. Modeling Fragile X Syndrome. Modeling Fragile X Syndrome
297
335
.
Tatsuki Koike, Takafumi Takai, Yasutaka Hoashi, Masaharu Nakayama, Yohei Kosugi, Masato Nakashima, Shin-ichi Yoshikubo, Keisuke Hirai & Osamu Uchikawa. (2011)
Synthesis of a Novel Series of Tricyclic Dihydrofuran Derivatives: Discovery of 8,9-Dihydrofuro[3,2-
c
]pyrazolo[1,5-
a
]pyridines as Melatonin Receptor (MT
1
/MT
2
) Ligands
. Journal of Medicinal Chemistry 54:12, pages 4207-4218.
Crossref
Crossref
Tatsuki Koike, Yasutaka Hoashi, Takafumi Takai, Masaharu Nakayama, Nobuhito Yukuhiro, Takashi Ishikawa, Keisuke Hirai & Osamu Uchikawa. (2011)
1,6-Dihydro-2
H
-indeno[5,4-
b
]furan Derivatives: Design, Synthesis, and Pharmacological Characterization of a Novel Class of Highly Potent MT
2
-Selective Agonists
. Journal of Medicinal Chemistry 54:9, pages 3436-3444.
Crossref
Crossref
Guiying Li, Hao Zhou, Yu Jiang, Holger Keim, Sidney W. Topiol, Suresh B. Poda, Yong Ren, Gamini Chandrasena & Darío Doller. (2011) Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands. Bioorganic & Medicinal Chemistry Letters 21:4, pages 1236-1242.
Crossref
Crossref
David Heckman, Mohamed I. Attia, Mira A. M. Behnam, Amal M. Y. Mohsen, Christian Markl, Justin Julius, Shalini Sethi, Paula A. Witt-Enderby & Darius P. Zlotos. (2011) 2-[(1,3-Dihydro-2H-isoindol-2-yl)methyl]melatonin – a novel MT2-selective melatonin receptor antagonist. MedChemComm 2:10, pages 991.
Crossref
Crossref
Elmar Peschke & Eckhard Mühlbauer. (2010) New evidence for a role of melatonin in glucose regulation. Best Practice & Research Clinical Endocrinology & Metabolism 24:5, pages 829-841.
Crossref
Crossref